HIGHLIGHTS
- who: Reed Mszar and colleagues from the Department of Physiology, Georgetown University, Washington, DC, USA have published the Article: Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia, in the Journal: (JOURNAL)
- what: HTG is commonly encountered in the primary and secondary medical care of patients, especially in those with DM and other cardiometabolic conditions, and contributes to a higher risk for ASCVD and AP.
- how: The GISSI-P study was conducted in patients with a recent MI (u22643 months) and found that low doses of EPA+DHA was beneficial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.